-
Pfizer skids after Q4 PAT slips 2% to Rs 101 crore
In India, the COVID-19 pandemic continued to develop rapidly into 2021, with a significant rise in the number of cases.
-
Pfizer tells Centre its Covid-19 vaccine suitable for all aged 12 and above
Pfizer has urged the Indian government to rely upon WHO's testing pathways of reliance on testing certificates from country of origin instead of manda
-
Moderna’s single-dose vaccine in India likely next year; Pfizer ready with 5 cr doses for 2021
The Health Ministry has also been asked to take an early decision on Cipla's request regarding support required by them for procurement of Moderna vac
-
Money9 Edit | Pharma companies should balance affordability and profits
Profit maximisation should not be sole driver of business in this critical hour of mankind and pharma companies should put compassion over commerce
-
Pfizer, Moderna declined to sell Covid vaccines to Delhi government: Kejriwal
All the 400 vaccination sites for the 18-44 age group have been closed in Delhi after the vaccine stock was over.
-
Covid-19 vaccine: States float global tenders to ramp up vaccination drive
Maharashtra, Kerala, Delhi are among the states that have already floated global tenders while Bihar and West Bengal are also mulling floating similar
-
Covid Vaccination: Bridging the wide gap in global inoculation
With the rollout of vaccines across the globe, there needs to be a systematic and flawless approach to ensure the equitable supply of vaccines happeni
-
Covid Crisis: Pfizer donates covid-19 treatment drugs worth $70 million to India
"We are donating these medicines to help make sure that every COVID-19 patient in every public hospital across the country can have access to the Pfiz
-
Money9 Edit | The opportunity in the challenge
The COVID-19 second surge has singed the nation but there is an opportunity to be grabbed with both hands
-
Covid-19: USTR in talks with Pfizer, AstraZeneca over TRIPS waiver on vaccines
The virtual meeting was set up to discuss increasing vaccine production, global health issues, and the proposed waiver to certain provisions of the WT
